SCHEMBL2907607

SCHEMBL2907607

COCCOC(=O)N(c1ccc(NC(=O)c2cc(N3C(=O)CCNC3=O)cc(C(C)(C)C)c2OC)cc1)S(C)(=O)=O

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.34
HSD17B10 Q99714 3/20 0.34
NR1H4 Q96RI1 1/20 0.34
TSHR P16473 1/20 0.34
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
USP2 O75604 2/20 0.33
KDM4E B2RXH2 1/20 0.33
BCL2 P10415 1/20 0.32
F10 P00742 1/20 0.32
ALDH1A1 P00352 2/20 0.31
TP53 P04637 2/20 0.31
LMNA P02545 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
ITGA4 P13612 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CRBN Q96SW2 1/20 0.30
HPGD P15428 2/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2910166 0.93 MAPT (0.36) MAPTHSD17B10NR1H4TSHRNPC1
SCHEMBL15654048 0.91 BCL2 (0.34) MAPTHSD17B10NR1H4TSHRNPC1
SCHEMBL2907867 0.89 NR1H4 (0.35) MAPTHSD17B10NR1H4TSHRNPC1
SCHEMBL2914099 0.87 NR1H4 (0.35) MAPTHSD17B10NR1H4TSHRNPC1
SCHEMBL2915395 0.87 BCL2 (0.36) MAPTHSD17B10NR1H4TSHRNPC1
SCHEMBL2907495 0.86 NR1H4 (0.36) MAPTHSD17B10NR1H4TSHRNPC1
SCHEMBL2907827 0.85 LMNA (0.46) MAPTHSD17B10NR1H4TSHRNPC1
SCHEMBL2913231 0.85 MAPT (0.34) MAPTHSD17B10NR1H4TSHRNPC1
SCHEMBL2907218 0.85 NR1H4 (0.38) MAPTHSD17B10NR1H4TSHRNPC1
SCHEMBL1530870 0.84 AURKB (0.40) MAPTHSD17B10NR1H4TSHRNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2222646-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C Abbott Laboratories (US) 2010-09-01 EP disclosed
WO-2009039127-A1 URACIL OR THYMINE DERIVATIVE FOR TREATING HEPATITIS C ABBOTT LABORATORIES (US) 2009-03-26 WO disclosed